Pharmaceutical Business review

Iomai stockholders approve merger with Intercell subsidiary

Approximately 71.6% of Iomai’s outstanding shares entitled to vote at the special meeting approved the merger, representing approximately 99.9% of the votes cast.

The transaction remains subject to certain closing conditions. Assuming satisfaction of the remaining conditions, the transaction is anticipated to be completed on or about August 5, 2008.